))
Establishing Direct-to and from-Patient Clinical Trials (Part 1)
Manage episode 402253684 series 3554424
Indhold leveret af Quick Group of Companies. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Quick Group of Companies eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Critically ill patients increasingly can participate in life saving and life changing cell & gene therapy clinical trials without having to leave their homes with the Direct- to -Patient and Direct- from -Patient model. So how do you set up these supply chains? How do you mitigate risk? And how do you ensure they’re resilient? Mike Sweeney, QuickSTAT’s Global Head of Strategy for CGT and Direct to Patient products, explains.
6 episoder
Del
